Session: Moderated Oral ePoster Session 06 - Bladder Cancer - Clinical and Bladder Cancer - Basic Science
MP-04.04: Encore Durability Results From Bond-003 Cohort C- Phase 3, Single-Arm Study of Intravesical Cretostimogene Grenadenorepvec for High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in Situ
